Gene therapy development
4D Molecular Therapeutics develops genetic medicines that use engineered viral vectors to deliver new DNA into cells. Its work covers designing product candidates, running laboratory and clinical studies, and advancing t...
Decide at what price you'd be comfortable buying and we'll help you stay ready.
4D Molecular Therapeutics is a gene therapy company that designs and develops treatments based on adeno-associated virus, or AAV, vectors. In simple terms, it tries to deliver working genes into cells to treat diseases at the source, rather than managing symptoms. Its main work is in diseases of the eye, heart, lungs, and other tissues where a one-time genetic treatment could be valuable.
The company does not sell a broad portfolio of marketed drugs. It earns money through research-stage development, collaboration deals, and, if its programs succeed, future drug sales or licensing arrangements. Its customers today are mainly research partners, clinical trial sites, and eventually doctors, hospitals, and patients if any of its therapies win approval.
What makes 4D Molecular Therapeutics different is its focus on engineering better viral delivery systems for gene therapy. That delivery step is the hard part in this field, because the gene has to reach the right cells safely and efficiently. The company is really selling a technical platform and a pipeline of drug candidates built on that platform, which puts it in the category of high-risk, long-development biotech rather than a traditional drug maker.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more